期刊
APPLIED CLAY SCIENCE
卷 101, 期 -, 页码 288-296出版社
ELSEVIER
DOI: 10.1016/j.clay.2014.09.004
关键词
5-Fluorouracil; Montmorillonite; Sustained release; Oral drug delivery
资金
- University of Tabriz
The objective of this study was to develop a sustained drug release system for 5-fluorouracil (5-FU), an anticancer drug, to improve its half-life. 5-Fluorouracil was loaded on montmorillonite (Mt) layers through the preparation of 5-FU/Mt nanocomposite by an intercalation method. In order to retard the drug release in the gastric environment, the prepared 5-FU/Mt nanocomposite was compounded with alginate (Alg), and further coated with chitosan (CS). This novel drug delivery system was characterized by Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), and scanning electron microscopy (SEM) analyses. By in vitro experiments the effects of Mt contents and pH of the release media on the release rate of the drug were investigated. According to the results, the Alg-CS/5-FU/Mt nanocomposite system containing 30 wt.% Mt in the release media with the pH of 7.4 effectively sustained the drug release and the time for 50% release, T-50%, is about 8 h. The release profile of 5-FU from the Alg-CS/5-FU/Mt nanocomposite system was best fitted by the Korsmeyer-Peppas kinetic model suggesting the diffusion controlled release mechanism. The prepared Alg-CS/5-FU/Mt nanocomposite system is suitable for the delivery of 5-FU in the small intestine with a controlled manner. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据